Close
Novotech
Jabsco PureFlo 21 Single Use

News

Pfizer buys Swiss preclinical stage firm Redvax

Pfizer has purchased a controlling stake in Redvax, a spin-off from Swiss biopharmaceutical firm Redbiotec. Terms of the transaction were not disclosed.Redvax is a preclinical stage company, which develops multi-component virus-like particles (VLPs) and other protein...

US researchers claim random mutations are responsible for certain cancers

Scientists from US-based Johns Hopkins Kimmel Cancer Centre have developed a statistical model, which measures the proportion of cancer incidence across many tissue types caused by random mutations. Random mutations occur when stem cells divide.Johns Hopkins...

Mylan and Gilead partner for TAF-based HIV treatments in developing markets

Mylan Laboratories has signed an agreement with Gilead Sciences to increase access to Tenofovir Alafenamide (TAF) based HIV treatments in developing countries. Mylan received non-exclusive rights to manufacture and distribute TAF as both a single agent...

AstraZeneca (AZ) and Eli Lilly have started AMARANTH, a phase II/III study investigating a potential treatment for early Alzheimer’s disease.

The trial will examine oral beta secretase cleaving enzyme (BACE) inhibitor AZD3293, also known as LY3314814, which reduced levels of amyloid-beta in the cerebro-spinal fluid of Alzheimer's patients and healthy volunteers in phase I studies. Other...

Pfizer establishes gene therapy unit for rare disease research

Researchers at Washington University School of Medicine in St. Louis, US, have reported preliminary data from a small clinical trial of a new breast cancer vaccine. Led by Washington University breast cancer surgeon and senior author...

EFPIA hails joint action on counterfeit drugs

The pan-European medicines verification system uses an anti-tampering device together with 2D barcoding to verify the authenticity of medicinal products and is currently being implemented with all supply chain stakeholders in Europe. It is being introduced...

Washington University-developed new breast cancer vaccine shows promise

Researchers at Washington University School of Medicine in St. Louis, US, have reported preliminary data from a small clinical trial of a new breast cancer vaccine.   Led by Washington University breast cancer surgeon and senior...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »